https://marshallislandshealthcarebrief.com/article/905140755-upcoming-national-women-s-health-week-promoting-scalp-care-and-breathable-wig-solutions Marshall Islands Healthcare Brief en PressRelease 2026-04-11T14:00:00+00:00 Upcoming National Women’s Health Week: Promoting Scalp Care and Breathable Wig Solutions https://ml.globenewswire.com/media/OTI3YTJhY2UtNjYzMS00YWRhLWE4MTgtYTNmYTI2NWY1Yjg5LTEzMTk4MDUtMjAyNi0wNC0xMS1lbg==/tiny/Klaiyi-Hair.png https://marshallislandshealthcarebrief.com/article/905116581-biontech-and-dualitybio-s-antibody-drug-conjugate-trastuzumab-pamirtecan-demonstrated-clinically-meaningful-efficacy-in-patients-with-her2-expressing Marshall Islands Healthcare Brief en PressRelease 2026-04-11T11:00:00+00:00 BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/190705-biontech-logo-rgb-dark-green-preferred-0-png.png https://marshallislandshealthcarebrief.com/article/905116769-biontechs-und-dualitybios-antik-rper-wirkstoff-konjugat-kandidat-trastuzumab-pamirtecan-zeigte-klinisch-relevante-wirksamkeit-bei-patientinnen-mit Marshall Islands Healthcare Brief en PressRelease 2026-04-11T11:00:00+00:00 BioNTechs und DualityBios Antikörper-Wirkstoff-Konjugat-Kandidat Trastuzumab Pamirtecan zeigte klinisch relevante Wirksamkeit bei Patientinnen mit rezidivierendem HER2-exprimierendem Gebärmutterkrebs https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/ https://marshallislandshealthcarebrief.com/article/905057231-neurosalt-under-investigation-what-the-2026-formulation-transparency-review-reveals-about-botanical-ingredients-dosage-disclosure-and-consumer Marshall Islands Healthcare Brief en PressRelease 2026-04-11T03:29:36+00:00 NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification https://zingfast.com/wp-content/uploads/2026/04/NeuroSalt-Reviews.jpg https://marshallislandshealthcarebrief.com/article/905024584-gentle-patches-claims-evaluated-2026-consumer-interest-rises-around-transdermal-wellness-patch-ingredients-product-lineup-and-policy-transparency Marshall Islands Healthcare Brief en PressRelease 2026-04-10T23:41:02+00:00 Gentle Patches Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, and Policy Transparency https://zingfast.com/wp-content/uploads/2026/04/Gentle-Patches.jpg https://marshallislandshealthcarebrief.com/article/905007017-glo-spa-rkle-aesthetics-and-medical-spa-unveils-new-state-of-the-art-location-in-lubbock-texas Marshall Islands Healthcare Brief en PressRelease 2026-04-10T23:12:00+00:00 Glo & Spa-rkle Aesthetics and Medical Spa Unveils New State-of-the-Art Location in Lubbock, Texas https://pressranger.s3.us-west-1.amazonaws.com/3228357/Image-4-10-26-at-3.57%E2%80%AFPM.jpeg https://marshallislandshealthcarebrief.com/article/905007248-ivy-rx-claims-evaluated-2026-compounded-glp-1-telehealth-program-details-monthly-pricing-structure-clinician-access-model-and-patient-eligibility Marshall Islands Healthcare Brief en PressRelease 2026-04-10T22:54:36+00:00 IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information https://zingfast.com/wp-content/uploads/2026/04/Ivy-Rx.jpg https://marshallislandshealthcarebrief.com/article/904991023-readyrx-nad-rx-claims-evaluated-2026-update-highlights-changes-in-prescription-nad-nasal-spray-and-injection-access-pricing-and-telehealth Marshall Islands Healthcare Brief en PressRelease 2026-04-10T21:13:08+00:00 ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility https://zingfast.com/wp-content/uploads/2026/04/ReadyRx-NAD-Injection-ReadyRx-NAD-Nasal-Spray.jpg https://marshallislandshealthcarebrief.com/article/904990418-replimune-receives-complete-response-letter-from-the-fda-for-rp1-biologics-license-application-for-the-treatment-of-advanced-melanoma Marshall Islands Healthcare Brief en PressRelease 2026-04-10T21:02:32+00:00 Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma https://ml.globenewswire.com/media/Y2ExYzg2MzEtNjQxMi00MmIyLTg5NjQtM2JhYTU0YjVkOTAwLTExMjIxMDEtMjAyNi0wNC0xMC1lbg==/tiny/Replimune-Inc-.png https://marshallislandshealthcarebrief.com/article/904990052-pelthos-therapeutics-announces-cfo-transition Marshall Islands Healthcare Brief en PressRelease 2026-04-10T21:00:00+00:00 Pelthos Therapeutics Announces CFO Transition https://ml.globenewswire.com/media/7d71f2d0-a48f-4fe0-a49c-138de21bc0e1/small/pelthos-logo-rgb-png.png https://marshallislandshealthcarebrief.com/article/904989897-vera-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Marshall Islands Healthcare Brief en PressRelease 2026-04-10T20:30:00+00:00 Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/b5c9081c-e6d9-44f7-abd0-0997a3c713f2/small/vera-thumbnail-jpg.jpg https://marshallislandshealthcarebrief.com/article/904990169-mesoblast-receives-ind-clearance-from-fda-to-directly-proceed-to-registrational-trial-for-approval-of-ryoncil-in-duchenne-muscular-dystrophy Marshall Islands Healthcare Brief en PressRelease 2026-04-10T20:09:52+00:00 Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png https://marshallislandshealthcarebrief.com/article/904989976-spyre-therapeutics-to-host-conference-call-to-report-spy001-part-a-induction-topline-results-from-skyline-trial-in-moderate-to-severe-ulcerative Marshall Islands Healthcare Brief en PressRelease 2026-04-10T20:05:00+00:00 Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026 https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://marshallislandshealthcarebrief.com/article/904990021-korro-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Marshall Islands Healthcare Brief en PressRelease 2026-04-10T20:05:00+00:00 Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://marshallislandshealthcarebrief.com/article/904989775-allogene-therapeutics-to-announce-interim-futility-analysis-data-from-its-pivotal-phase-2-alpha3-trial-with-cemacabtagene-ansegedleucel-cema-cel-in Marshall Islands Healthcare Brief en PressRelease 2026-04-10T20:02:00+00:00 Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026 https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://marshallislandshealthcarebrief.com/article/904973258-iradimed-corporation-to-participate-at-the-25th-annual-needham-virtual-healthcare-conference Marshall Islands Healthcare Brief en PressRelease 2026-04-10T19:14:57+00:00 IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/f353c867-559d-43a8-935c-ab497045e743/small/logo-gif.gif https://marshallislandshealthcarebrief.com/article/904971775-best-medical-alert-systems-2026-bay-alarm-medical-awarded-best-medical-alert-system Marshall Islands Healthcare Brief en PressRelease 2026-04-10T19:06:00+00:00 Best Medical Alert Systems 2026: Bay Alarm Medical Awarded Best Medical Alert System https://pressranger.s3.us-west-1.amazonaws.com/3226873/bay-alarm-medical.png https://marshallislandshealthcarebrief.com/article/904973080-suja-life-announces-filing-of-registration-statement-for-proposed-initial-public-offering Marshall Islands Healthcare Brief en PressRelease 2026-04-10T18:52:29+00:00 Suja Life Announces Filing of Registration Statement for Proposed Initial Public Offering https://ml.globenewswire.com/media/9022887d-dd69-416f-9a4b-ce5e546d75e4/small/suja-life-horizontal-black-1-png.png https://marshallislandshealthcarebrief.com/article/904971348-matricis-ai-launches-first-u-s-clinical-pilot-of-endomai-for-ai-assisted-detection-of-endometriosis-with-simonmed Marshall Islands Healthcare Brief en PressRelease 2026-04-10T18:29:00+00:00 Matricis.ai Launches First U.S. Clinical Pilot of EndomAI for AI-Assisted Detection of Endometriosis with SimonMed https://ml.globenewswire.com/media/c74fe43e-1082-4594-9a53-fb3309961e2d/small/matricis-ai-logo.png https://marshallislandshealthcarebrief.com/article/904972086-novarad-to-showcase-surgical-augmented-reality-platform-visar-at-sir-2026 Marshall Islands Healthcare Brief en PressRelease 2026-04-10T17:32:18+00:00 Novarad to Showcase Surgical Augmented Reality Platform VisAR at SIR 2026 https://ml.globenewswire.com/media/MGZkMzk0ZWUtY2UxOS00MDNiLWI3MGYtNGFjN2M2OTQ3MmZkLTEyOTc0ODMtMjAyNi0wNC0xMC1lbg==/tiny/Novarad-Corporation.png https://marshallislandshealthcarebrief.com/article/904971600-the-ebony-canal-announces-global-birth-equity-tour-following-award-winning-season Marshall Islands Healthcare Brief en PressRelease 2026-04-10T17:10:57+00:00 The Ebony Canal Announces Global Birth Equity Tour Following Award-Winning Season https://ml.globenewswire.com/media/OWU1NmMyZTQtODMyMC00N2JkLWIwMjYtZTJlYmQyMzJjNjQzLTUwMDE0NTYwOC0yMDI2LTA0LTEwLWVu/tiny/The-Ebony-Canal.png https://marshallislandshealthcarebrief.com/article/904953706-humber-river-health-renames-wilson-site-hennick-humber-hospital-following-transformational-50-million-gift Marshall Islands Healthcare Brief en PressRelease 2026-04-10T15:00:00+00:00 Humber River Health Renames Wilson Site Hennick Humber Hospital Following Transformational $50 Million Gift https://ml.globenewswire.com/media/44df2e20-b7f3-4ea6-ab08-40b257b45435/medium/hennick-humber-hospital.jpg https://marshallislandshealthcarebrief.com/article/904937059-get-medicaid-facts-new-site-and-toolkit-launched-to-educate-public-about-looming-medicaid-eligibility-changes Marshall Islands Healthcare Brief en PressRelease 2026-04-10T13:25:37+00:00 Get Medicaid Facts: New Site and Toolkit Launched to Educate Public About Looming Medicaid Eligibility Changes https://ml.globenewswire.com/media/NWY4ZTZiZWMtNmJmYS00ZmJlLWFlZTEtYzlmZDRkYTlhZWFmLTUwMDEyMzk3My0yMDI2LTA0LTEwLWVu/tiny/Cook-County-Health.png https://marshallislandshealthcarebrief.com/article/904917565-oncotelic-therapeutics-inc-otcqb-otlc-strengthening-position-with-ai-driven-tech-in-automated-compliance-space Marshall Islands Healthcare Brief en PressRelease 2026-04-10T12:30:00+00:00 Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://marshallislandshealthcarebrief.com/article/904917568-nightfood-holdings-inc-otcqb-ngtf-brings-ai-enabled-robotics-platform-to-growing-pharma-manufacturing-space Marshall Islands Healthcare Brief en PressRelease 2026-04-10T12:30:00+00:00 Nightfood Holdings Inc. (OTCQB: NGTF) Brings AI-Enabled Robotics Platform to Growing Pharma Manufacturing Space https://ml.globenewswire.com/media/941038f9-3586-4d7d-bf4a-83bf88d43654/small/techforcelogo-png.png https://marshallislandshealthcarebrief.com/article/904917673-biomx-acquires-zorronet-autonomous-ai-command-and-control-platform-for-real-time-defense-and-security-applications Marshall Islands Healthcare Brief en PressRelease 2026-04-10T12:30:00+00:00 BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications https://ml.globenewswire.com/media/MjFhYTYyOWYtOGEzOC00MTVkLWE4ZDctNDJjNDViNTY2ZjNjLTEzMjE4NzEtMjAyNi0wNC0xMC1lbg==/tiny/BiomX.png https://marshallislandshealthcarebrief.com/article/904919631-annovis-closes-10-million-offering-extending-cash-runway-through-phase-3-alzheimer-s-disease-6-month-nda-submission Marshall Islands Healthcare Brief en PressRelease 2026-04-10T12:30:00+00:00 Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission https://ml.globenewswire.com/media/7ee459df-d33f-4f42-b27c-3bd20487d50c/small/annovis-corp-image-png.png https://marshallislandshealthcarebrief.com/article/904919901-fibrobiologics-presents-novel-thymus-organoid-platform-to-combat-age-related-immune-decline-at-keystone-symposia-on-aging-and-immunity Marshall Islands Healthcare Brief en PressRelease 2026-04-10T12:30:00+00:00 FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://marshallislandshealthcarebrief.com/article/904919848-global-bispecific-antibodies-market-to-reach-22-3-billion-by-2030-as-immuno-oncology-innovation-and-r-d-investment-accelerate Marshall Islands Healthcare Brief en PressRelease 2026-04-10T12:15:20+00:00 Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://marshallislandshealthcarebrief.com/article/904918119-lifemd-now-offering-eli-lilly-and-company-s-foundayo-orforglipron-a-new-glp-1-pill-for-weight-management Marshall Islands Healthcare Brief en PressRelease 2026-04-10T12:15:00+00:00 LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management https://ml.globenewswire.com/media/07c92c99-5645-4be8-a3b7-6d9392b7ccc4/small/lifemd-png.png https://marshallislandshealthcarebrief.com/article/904917358-enovis-to-host-first-quarter-2026-results-conference-call-on-may-7th Marshall Islands Healthcare Brief en PressRelease 2026-04-10T12:00:00+00:00 Enovis to Host First Quarter 2026 Results Conference Call on May 7th https://ml.globenewswire.com/media/b4532895-c0b7-4f6a-9a37-db4eefc89e3d/small/logo-enovis-jpg.jpg https://marshallislandshealthcarebrief.com/article/904917590-milestone-pharmaceuticals-announces-reset-psvt-registry-to-generate-real-world-evidence-on-cardamyst-etripamil-nasal-spray-in-patients-with-psvt Marshall Islands Healthcare Brief en PressRelease 2026-04-10T12:00:00+00:00 Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png https://marshallislandshealthcarebrief.com/article/904917681-unyte-health-acquires-vital-links-and-vital-sounds-developers-of-therapeutic-listening Marshall Islands Healthcare Brief en PressRelease 2026-04-10T12:00:00+00:00 Unyte Health Acquires Vital Links and Vital Sounds, Developers of Therapeutic Listening® https://ml.globenewswire.com/media/257d6598-31bf-4160-9eb6-1e813f9c32cd/medium/unyte-health-acquires-vital-links-and-vital-sounds.png https://marshallislandshealthcarebrief.com/article/904917560-neuraxis-inc-announces-preferred-stock-dividend Marshall Islands Healthcare Brief en PressRelease 2026-04-10T11:00:00+00:00 NeurAxis, Inc. Announces Preferred Stock Dividend https://ml.globenewswire.com/media/a1e3887d-3378-46c5-938d-2b0d5a7c825f/small/neuraxis-logo-png.png https://marshallislandshealthcarebrief.com/article/904917584-opus-genetics-announces-data-presentations-at-the-2026-american-society-of-cataract-and-refractive-surgery-annual-meeting Marshall Islands Healthcare Brief en PressRelease 2026-04-10T10:59:00+00:00 Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg https://marshallislandshealthcarebrief.com/article/904857718-zhen-ao-group-showcases-core-5-nucleotide-breakthroughs-in-cambridge-illuminating-a-chinese-path-for-global-technology-driven-anti-aging Marshall Islands Healthcare Brief en PressRelease 2026-04-10T04:47:14+00:00 Zhen-Ao Group Showcases Core 5'-Nucleotide Breakthroughs in Cambridge, Illuminating a Chinese Path for Global Technology-Driven Anti-Aging https://ml.globenewswire.com/media/7fc5c9bd-2021-40e4-9c76-d7aad178e72d/small/zhenao-logo-png.png https://marshallislandshealthcarebrief.com/article/904838879-tricare-now-covers-online-therapy-in-new-york-0-copay-for-active-duty-families-through-mmhc Marshall Islands Healthcare Brief en PressRelease 2026-04-10T03:05:25+00:00 TRICARE Now Covers Online Therapy in New York — $0 Copay for Active-Duty Families Through MMHC https://ml.globenewswire.com/media/0512a307-6a81-4fb8-b8da-95eb0b0d71b3/small/mmhc-logo-2024-png.png https://marshallislandshealthcarebrief.com/article/904819062-best-acv-gummies-claims-evaluated-what-ingredient-labels-actually-disclose-vs-what-marketing-pages-emphasize-2026-consumer-transparency-update Marshall Islands Healthcare Brief en PressRelease 2026-04-10T00:32:40+00:00 Best ACV Gummies Claims Evaluated: What Ingredient Labels Actually Disclose vs. What Marketing Pages Emphasize — 2026 Consumer Transparency Update https://zingfast.com/wp-content/uploads/2026/04/Best-ACV-Gummies.jpg https://marshallislandshealthcarebrief.com/article/904818976-vita-smart-cup-massager-claims-evaluated-2026-report-on-suction-therapy-red-light-technology-and-what-consumers-should-know-before-buying Marshall Islands Healthcare Brief en PressRelease 2026-04-09T23:59:35+00:00 Vita Smart Cup Massager Claims Evaluated: 2026 Report on Suction Therapy, Red Light Technology, and What Consumers Should Know Before Buying https://zingfast.com/wp-content/uploads/2026/04/Vita-Smart-Cup-Massager.jpg https://marshallislandshealthcarebrief.com/article/904800324-fda-accepts-nda-for-tlx101-px-pixclara Marshall Islands Healthcare Brief en PressRelease 2026-04-09T22:51:29+00:00 FDA Accepts NDA for TLX101-Px (Pixclara®) https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://marshallislandshealthcarebrief.com/article/904800214-extendicare-announces-450-million-inaugural-offering-of-investment-grade-senior-unsecured-notes Marshall Islands Healthcare Brief en PressRelease 2026-04-09T21:55:05+00:00 Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://marshallislandshealthcarebrief.com/article/904786974-strata-critical-medical-to-present-at-the-25th-annual-needham-virtual-healthcare-conference Marshall Islands Healthcare Brief en PressRelease 2026-04-09T21:11:28+00:00 Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/199716f4-aabd-4469-85e4-a085a6613ffe/small/stratacritical-finallogo-jpg.jpg https://marshallislandshealthcarebrief.com/article/904787587-dental-care-of-stamford-challenges-the-myths-holding-stamford-residents-back-from-the-smile-they-want Marshall Islands Healthcare Brief en PressRelease 2026-04-09T21:11:01+00:00 Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Want https://ml.globenewswire.com/Resource/Download/6c9fe8d8-6ec0-4c95-833e-9fcb8ecc4b5a/image2.png https://marshallislandshealthcarebrief.com/article/904785556-emergent-biosolutions-partners-with-british-columbia-to-supply-narcan-nasal-spray-for-the-launch-of-the-expanded-bc-take-home-naloxone-program Marshall Islands Healthcare Brief en PressRelease 2026-04-09T20:25:00+00:00 Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://marshallislandshealthcarebrief.com/article/904785692-ehealth-exchange-demonstrates-real-world-patient-access-capability-advancing-cms-aligned-network-goals Marshall Islands Healthcare Brief en PressRelease 2026-04-09T20:25:00+00:00 eHealth Exchange Demonstrates Real-World Patient Access Capability, Advancing CMS-Aligned Network Goals https://ml.globenewswire.com/media/8cc7b0d1-2d24-41da-b3bc-54e9953144ee/small/ehealth-logo-png.png https://marshallislandshealthcarebrief.com/article/904785369-sobi-receives-health-canada-approval-for-empaveli-pegcetacoplan-for-the-treatment-of-c3g-and-primary-ic-mpgn Marshall Islands Healthcare Brief en PressRelease 2026-04-09T20:21:28+00:00 Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN https://ml.globenewswire.com/media/571c0204-b76a-4bba-b586-03bedbc971b9/small/sobi-logo-png-0-png.png https://marshallislandshealthcarebrief.com/article/904785492-sobi-re-oit-l-autorisation-par-sant-canada-pour-empavelimd-pegc-tacoplan-dans-le-traitement-de-la-gc3-et-de-la-gnmp-ci-primitive Marshall Islands Healthcare Brief en PressRelease 2026-04-09T20:21:28+00:00 Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive. https://ml.globenewswire.com/media/571c0204-b76a-4bba-b586-03bedbc971b9/small/ https://marshallislandshealthcarebrief.com/article/904783453-certara-to-report-first-quarter-2026-financial-results-on-may-11th-2026 Marshall Islands Healthcare Brief en PressRelease 2026-04-09T20:15:00+00:00 Certara to Report First Quarter 2026 Financial Results on May 11th, 2026 https://ml.globenewswire.com/media/6da79355-1c12-4676-93c4-f765b2948060/small/rgbcertara-logo-large-blackhigh-res-png.png https://marshallislandshealthcarebrief.com/article/904785175-solana-company-nasdaq-hsdt-appoints-madelene-gani-as-chief-operating-officer-and-deputy-cfo-to-lead-next-phase-of-growth Marshall Islands Healthcare Brief en PressRelease 2026-04-09T20:15:00+00:00 Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth https://ml.globenewswire.com/media/1986b97e-8656-4213-9218-ae51324d696d/small/solana-company-main-black-png.png https://marshallislandshealthcarebrief.com/article/904781755-lb-pharmaceuticals-announces-presentation-at-25th-annual-needham-virtual-healthcare-conference Marshall Islands Healthcare Brief en PressRelease 2026-04-09T20:05:00+00:00 LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference https://ml.globenewswire.com/media/90903161-520e-409f-b2ac-dd18677b4bb8/small/lb-pharma-logo-png.png https://marshallislandshealthcarebrief.com/article/904782848-procept-biorobotics-to-report-first-quarter-2026-financial-results-on-april-29-2026 Marshall Islands Healthcare Brief en PressRelease 2026-04-09T20:05:00+00:00 PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026 https://ml.globenewswire.com/media/fc9b1b79-13a0-4245-a974-081e3ceaafcb/small/procept-logo-png.PNG https://marshallislandshealthcarebrief.com/article/904783280-verrica-pharmaceuticals-announces-acceptance-of-late-breaking-abstract-highlighting-potential-abscopal-effect-of-vp-315-for-the-treatment-of-basal Marshall Islands Healthcare Brief en PressRelease 2026-04-09T20:05:00+00:00 Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg https://marshallislandshealthcarebrief.com/article/904782846-cardiff-oncology-announces-key-leadership-appointments-to-strengthen-executive-team-for-next-phase-of-growth Marshall Islands Healthcare Brief en PressRelease 2026-04-09T20:01:00+00:00 Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg https://marshallislandshealthcarebrief.com/article/904784401-standard-dental-labs-inc-files-2025-annual-report-and-audited-financial-statements-2025-following-transformational-year-and-recent-acquisition Marshall Islands Healthcare Brief en PressRelease 2026-04-09T20:00:00+00:00 Standard Dental Labs Inc. Files 2025 Annual Report and Audited Financial Statements 2025 Following Transformational Year and Recent Acquisition Positioning Company for Potential, Significant Revenue Growth https://ml.globenewswire.com/media/2369a47c-d78d-419f-acb4-14fafec588aa/small/sdl-logo-2023-02-png.png https://marshallislandshealthcarebrief.com/article/904784167-clinnexus-to-participate-as-featured-speaker-in-suncoast-ventures-gateway-conference-on-healthcare-innovation Marshall Islands Healthcare Brief en PressRelease 2026-04-09T19:36:29+00:00 ClinNEXUS to Participate as Featured Speaker in Suncoast Ventures Gateway Conference on Healthcare Innovation https://ml.globenewswire.com/media/adea948f-ec79-4ec6-bebe-ce3e1943b48d/small/clinnexus-png.png https://marshallislandshealthcarebrief.com/article/904762792-medical-centre-in-blacktown-goes-bulk-billed Marshall Islands Healthcare Brief en PressRelease 2026-04-09T18:53:00+00:00 Medical Centre in Blacktown goes Bulk Billed https://pressranger.s3.us-west-1.amazonaws.com/3226112/Kildare-Road-Medical-Centre-Project3-1200x616.jpg